0.1300CAD+4.00%Mkt Cap: 16.35M CADP/E: —Last update: 2026-06-01
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmace…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap16.35M CAD
Enterprise Value23.43M CAD
Revenue (TTM)25.83M CAD
Gross Profit13.52M CAD
Net Income (TTM)-2.84M CAD
Revenue/Share0.2210 CAD
Last Price0.1300 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees112
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA05368K1003
Valuation
P/E (Trailing)—
P/E (Forward)-2.08
PEG—
EV/EBITDA-8.76
EV/Revenue0.91
P/S0.61
P/B3.79
EPS (TTM)-0.02
EPS (Forward)-0.06
52W Range
0.12005% of range0.3100
52W High0.3100 CAD
52W Low0.1200 CAD
Profitability
Gross Margin53.06%
Oper. Margin-4.63%
EBITDA Margin-10.35%
Profit Margin-11.16%
ROE-100.02%
ROA-13.39%
Growth
Revenue Growth5.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.18M CAD
CapEx (TTM)255.87K CAD
FCF Margin-5.38%
FCF Yield-8.49%
Net Debt-372.10K CAD
Net Debt/EBITDA0.14
Balance Sheet
Debt/Equity0.00
Current Ratio0.96
Quick Ratio0.44
Book Value/Sh0.0330 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.125.79M
Float104.29M
Insiders23.17%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.07%
Shares Short39.28K
Short (prev mo.)41.32K
Technical
SMA 500.1447 (-10.2%)
SMA 2000.2111 (-38.4%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)201.82K
Avg Vol (10d)210.88K
Technical Indicators
RSI (14)35.7
MACD-0.0052
MACD Signal-0.0053
MACD Hist.+0.0001
BB Upper0.1452 CAD
BB Middle0.1335 CAD
BB Lower0.1218 CAD
BB Width17.59%
ATR (14)0.0073 CAD
Vol Ratio (20d)0.54x